Page last updated: 2024-10-26

dipyridamole and Extrasystole, Ventricular

dipyridamole has been researched along with Extrasystole, Ventricular in 2 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Virgilio, C1
Pak, S1
Arnell, T1
Donayre, C1
Lewis, RJ1
Stabile, BE1
White, R1
Rabin, DL1
Ali, A1
Barron, JT1

Other Studies

2 other studies available for dipyridamole and Extrasystole, Ventricular

ArticleYear
Cardiac assessment prior to vascular surgery: is dipyridamole-sestamibi necessary?
    Annals of vascular surgery, 1996, Volume: 10, Issue:4

    Topics: Age Factors; Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Coronary Arter

1996
Association of ventricular ectopy with nuclear scintigraphic perfusion defects during dipyridamole stress testing.
    Clinical cardiology, 1998, Volume: 21, Issue:2

    Topics: Aged; Dipyridamole; Electrocardiography; Exercise Test; Female; Humans; Infusions, Intravenous; Male

1998